1. Novartis to pay $678 to settle kickback claims — PhRMA sues Minnesota over insulin pricing law — Amgen Enbrel patents to be upheld through 2029 — See more on our front page news Stay updated with the latest pharma-related coronavirus news on our new page
    Dismiss Notice
  2. Do you have 7 minutes to fill out a quick survey about ordering food for work? You’ll be entered into a raffle to win a $100 Amazon.com gift card as a thank you for your time. click here
    Dismiss Notice

after cuts, still poor RD management

Discussion in 'Merck Lab Personnel' started by Anonymous, Jan 7, 2014 at 4:10 PM.

Tags: Add Tags
  1. Anonymous

    Anonymous Guest

    few good leaders and decision makers. keeping managers who pushed 5S? so many cuts difficult for projects to move foward. too many under achiever managers in WP with little discovery experience
     

  2. Anonymous

    Anonymous Guest

    What do you expect from a "pharmaceutical" company that doesn't have scientists in its upper management? Merck has top-down problems. Don't expect reorganization to change the direction of a company that has no direction to begin with. Shareholders have their head buried in the sand, IMO.
     
  3. Anonymous

    Anonymous Guest

    I only buy other pharma stocks. Management needs replacement. Few have pushed product to market. WP has too many executive levels with 2 page resumes. Roger make the changes.